Brief: Selecta Biosciences Inc Received Notice From Nasdaq It Is No Longer In Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq
03/06/2022 21:35
June 3 (Reuters) - Selecta Biosciences Inc SELB.O :
* SELECTA-ON MAY 31, 2022 CO RECEIVED NOTICE FROM NASDAQ IT
IS NO
LONGER IN COMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT FOR
CONTINUED LISTING ON NASDAQ
Further company coverage: SELB.O
Recent news on Cartesian Therapeutics
See all newsBrief: Cartesian Therapeutics Announces Additional Retreatment Data For Descartes-08 Highlighting Deep And Durable Responses In Patients With Myasthenia Gravis
Cartesian Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cartesian Therapeutics Q2 net income steady
Brief: Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million
Cartesian Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview